WuXi AppTec Purchases Instem's Provantis Software for Toxicology Facility in China

WuXi AppTec Purchases Instem's Provantis Software for Toxicology Facility in China

CONSHOHOCKEN, PA - August 5, 2009 - - Instem, a leading provider of early drug development software solutions, announced today that WuXi AppTec (WuXi) has purchased the ProvantisTM preclinical solution for its world-class facility in Suzhou, China. Wuxi will be deploying integrated modules for its General Toxicology, Clinical Pathology, Pathology and Formulations Departments for test item control.

ProvantisTM is a modern, fully integrated software system for single users and global organizations engaged in non-clinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, ProvantisTM streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment. ProvantisTM will be installed in WuXi's newly constructed, 314,000 square-feet toxicology facility in Suzhou, the largest of its kind in China. The facility will follow the "Guiding Principles in the Use of Animals in Toxicology" and will operate to AAALAC standards.

WuXi's purchase of ProvantisTM supports its ongoing commitment to providing the highest-quality services to help the world's leading pharmaceutical, biotechnology and medical device companies shorten the time and lower the cost of R&D. Benefits of the ProvantisTM software system include:

Time savings and increased study throughput
Improved quality via 21 CFR Part 11 compliance
Greater use of valuable resources
Faster response times to customer requests
Significant reduction of overhead costs for quality assurance
Overall increased capability to perform more studies


About WuXi AppTec and WuXi PharmaTech
WuXi PharmaTech (NYSE: WX) is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the pharmaceutical and medical device R&D process. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: http://www.wuxiapptec.com.

About Instem
Instem is a world-leading information solutions provider for the Life Sciences - accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. In addition to highly focused departmental and scientific solutions, Instem provides a range of Business Intelligence, Planning, Workflow Management, Dosage Formulation, Document Management and Report Compilation applications.

Suggested Articles

Half of patients in an early trial of Allogene's off-the-shelf CAR-T cells for lymphoma who received a higher dose of its antibody ALLO-647 responded.

Takeda is tossing out a Shire pipeline med after it couldn't find a buyer.

Ipsen's new hire arrives at a company reeling from a torrent six months that have crushed hopes for its $1 billion bet on a rare disease drug.